Skip to main content

Coronavirus research collection

© sdecoret / stock.adobe.com

To help keep our readers up-to-date on research and analysis related to the COVID-19 pandemic, we have created this collection of articles and other resources published in Cardiovascular Diabetology. New articles will be added on a monthly basis.

Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes
Oliver Schnell, Tadej Battelino, Richard Bergenstal, Matthias Blüher, Michael Böhm, Frank Brosius, Richard D. Carr, Antonio Ceriello, Thomas Forst, Francesco Giorgino, Bruno Guerci, Hiddo J. L. Heerspink, Baruch Itzhak, Linong Ji, Mikhail Kosiborod, Nebojša Lalić, Michael Lehrke, Nikolaus Marx, Michael Nauck, Helena W. Rodbard, Giuseppe M. C. Rosano, Peter Rossing, Lars Rydén, Francesca Santilli, Petra-Maria Schumm-Draeger, Per Olav Vandvik, Tina Vilsbøll, Christoph Wanner, Carol Wysham & Eberhard Standl 
Commentary  |   Published: 08 April 2022

Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study
Parth Shah, Kim Magee, Kiara H. Buccellato, McKenna Ismond & Jalisa Watson
Original investigation  |   Published: 14 February 2022

The management of type 2 diabetes before, during and after Covid‑19 infection: what is the evidence?
Leszek Czupryniak, Dror Dicker, Roger Lehmann, Martin Prázný, Guntram Schernthaner
Commentary  |   Published: 1 October 2021

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
José Miguel Rivera-Caravaca, Stephanie L. Harrison, Benjamin J. R. Buckley, Elnara Fazio-Eynullayeva, Paula Underhill, Francisco Marín, Gregory Y. H. Lip
Original investigation  |   Published: 4 September 2021

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
Etheresia Pretorius, Mare Vlok, Chantelle Venter, Johannes A. Bezuidenhout, Gert Jacobus Laubscher, Janami Steenkamp, Douglas B. Kell 
Original investigation  |   Published: 23 August 2021

Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients
Franck Phan, Samia Boussouar, Olivier Lucidarme, Mohamed Zarai, Joe-Elie Salem, Nadjia Kachenoura, Khaoula Bouazizi, Etienne Charpentier, Yasmine Niati, Hasnae Bekkaoui, Zahir Amoura, Alexis Mathian, Olivier Benveniste, 
Patrice Cacoub, Yves Allenbach, David Saadoun, Jean-Marc Lacorte, Salma Fourati, Suzanne Laroche, Agnes Hartemann, Olivier Bourron, Fabrizio Andreelli, Alban Redheuil, COVID-19 APHP.SU Group

Original investigation  |   Published: 12 August 2021

Epicardial adipose tissue and severe Coronavirus Disease 19
Hélène Bihan, Richard Heidar, Aude Beloeuvre, Lucie Allard, Elise Ouedraogo, Sopio Tatulashvili, Yacine Tandjaoui, Stephane Gaudry, Pierre-Yves Brillet, Emmanuel Cosson 
Original investigation  |   Published: 20 July 2021

Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching
Prateek Lohia, Shweta Kapur, Sindhuri Benjaram, Zachary Cantor, Navid Mahabadi, Tanveer Mir, M. Safwan Badr
Original investigation  |   Published: 10 July 2021

Metabolic syndrome and the plasma proteome: from association to causation
Mohamed A. Elhadad, Rory Wilson, Shaza B. Zaghlool, Cornelia Huth, Christian Gieger, Harald Grallert, Johannes Graumann, Wolfgang Rathmann
Original investigation  |   Published: 20 May 2021

Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug
Lorenzo Nesti, Domenico Tricò, Alessandro Mengozzi, Andrea Natali
Review  |   Published: 18 May 2021

Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, Maria Consiglia Trotta, Marisa De Feo, Ciro Maiello, Pasquale Mascolo, Francesco De Micco
Original investigation  |   Published: 7 May 2021

Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system
Michal Herman-Edelstein, Tali Guetta, Amir Barnea, Maayan Waldman, Naomi Ben-Dor, Yaron Barak, Ran Kornowski, Michael Arad
Original investigation  |   Published: 27 April 2021

PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes
Alessandra Giannella, Giulio Ceolotto, Claudia Maria Radu, Arianna Cattelan, Elisabetta Iori, Andrea Benetti, Fabrizio Fabris, Paolo Simioni
Original investigation  |   Published: 3 April 2021

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes
Oliver Schnell, Xavier Cos, Francesco Cosentino, Thomas Forst, Francesco Giorgino, Hiddo J. L. Heersprink, Mikhail Kosiborod, Christoph Wanner
Commentary  |   Published: 31 March 2021

Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic
Raúl Moreno, José-Luis Díez, José-Antonio Diarte, Pablo Salinas, José María de la Torre Hernández, Juan F. Andres-Cordón, Ramiro Trillo, Juan Alonso Briales
Original investigation  |   Published: 23 March 2021

Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study
Hyo-Jeong Ahn, Kyung-Do Han, Eue-Keun Choi, Jin-Hyung Jung, Soonil Kwon, So-Ryoung Lee, Seil Oh, Gregory Y. H. Lip
Original investigation  |   Published: 19 January 2021

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2022 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    55 days submission to accept (Median)

    2022 Usage 
    2,116,496 downloads
    14,109 Altmetric mentions